This is a study to compare the effects of a new drug for schizophrenia (AL-108) to a placebo in people suffering from schizophrenia. Researchers will focus on the new medication's effects on the cognitive problems associated with schizophrenia when it is added to the patients' existing treatments. This study is currently recruiting 60 schizophrenia patients from eight states to participate in this 12-week clinical trial.
Read moreMy relative was doing well on seroquel (quetiapine) but he took himself off it because of heart palpitations. He is now on olanzapine,... Read more »
In my last post, I discussed some of the changes in lifestyle that can help improve the heart health of people with schizophrenia. I'd... Read more »
Recently, I was reviewing the literature on tardive dyskinesia, and it struck me how frustrating it must be for patients who develop this... Read more »
The topic will be negative symptoms of schizophrenia, called this because they take away from or reduce functioning. Negative symptoms... Read more »
When I was a disc jockey, I'd mix intuitive segues: rock-n-roll and the blues, classical and punk. So, too, with my writing, I make... Read more »
According to a recent study, a new drug called lurasidone is safe and effective for treating patients hospitalized for acute schizophrenia. The study... Read more »
This is a study to compare the safety and cognitive effects of a new drug (GSK239512) to a placebo in people who have schizophrenia. This national... Read more »
Danish drugmaker Lundbeck is reporting that its new schizophrenia medication zicronapine was effective in a recent Phase II clinical trial. In the... Read more »
This is a study to examine how well a new drug for schizophrenia--currently known as AQW051--helps enhance various kinds of brain function in people... Read more »
Scientists may have found a way to target specific receptors in the brain so that drugs may better treat the cognitive and motor problems related to... Read more »